Trailing Twelve Months Revenue Growth: Portage Biotech Corp (PRTG)

Public company logo of portagebiotech.com (PRTG)

Despite a lack of profitability and a reliance on investment, Portage Biotech Inc. (PRTG) operates within the protected medical innovation sector, which remains insulated from macroeconomic fluctuations. The rolling 12-month sales growth rate compared to the previous year demonstrates current trends, where the 0.00 mark reflects the latest data. Portage Biotech Inc. (PRTG) is developing immunotherapy to combat solid tumors, targeting the checkpoint inhibitor market and patients with resistant forms of cancer.

Portage Biotech Inc. (PRTG): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 02/20/2024

Portage Biotech Inc. - analytical breakdowns and key metrics (PRTG)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:Portage
Brand item of Portage Biotech Corp

This indicator measures revenue dynamics over the last twelve months relative to the same period last year, allowing for an assessment of the stability of customer demand and the pace of business expansion. Analyzing the annual sales growth rate over a 12-month period is critically important for Portage Biotech Inc. (PRTG), as turnover volatility during the NKT-asset development stage may signal risks or, conversely, an increase in investment attractiveness for acquisition by pharma behemoths.

Who Portage Biotech Inc. competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Nuvectis Pharma, Inc. - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CHRS (Coherus BioSciences)|Corbus Pharma - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) CRDF (cardiffoncology.com)|BYSI: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth BioAtla Corp (BCAB)|Sales Growth YoY (Last Twelve Months) Lixte Biotechnology Holdings, Inc.|CTXR: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) CLRB|Sales Growth YoY (TTM) BioLineRx Corporation (BLRX)|Sales Growth YoY (Last Twelve Months) Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Trailing Twelve Months Sales Growth|KZIA: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Silexion Therapeutics|NuCana plc (NCNA) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Chimerix, Inc|Revenue Growth YoY (Last 12 Months) CYCC|Revenue Growth YoY (Last 12 Months) G1 Therapeutics (GTHX)|Sales Growth YoY (Last Twelve Months) Kronos Bio Corporation (KRON)|Kintara - Sales Growth YoY (Last 12 Months)|Oncternal Therapeutics, Inc. - Revenue Growth YoY (Last 12 Months)